Document is current

Any future updates will be listed below

Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison

Crossref DOI link: https://doi.org/10.1007/s12325-023-02640-9

Published Online: 2023-10-04

Published Print: 2023-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark